Cerebral Glioma
Conditions
Interventions
Subjects with highly suspected brain glioma group:None
Health control group:None
Sponsors
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
Eligibility
Sex/Gender
All
Age
19 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients over the age of 19 who agree to participate in the clinical trial; 2.Highly suspected glioma was reported after craniocerebral MRI plain scan + enhanced examination, and highly suspected glioma was judged by at least 2 physicians with titles above deputy chief physicians; 3.Can lie flat for an hour or more.
Exclusion criteria
Exclusion criteria: 1.Had a pacemaker implanted; 2.Metal implants in the body; 3.Claustrophobia; 4.Pregnant women; 5.Weigh more than 136 kilograms (about 300 pounds); 6.Patients who have received craniocerebral surgery or have been injured outside the craniocerebral; 7.Non-glioma patients confirmed by postoperative pathological diagnosis; 8.Have a history of drug or alcohol abuse; 9.Have a history of other craniocerebral, neurological, psychiatric diseases and brain trauma except glioma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional parameters of cerebral vascular autonomic regulation and phenotypic heterogeneity in gliomas;Correlation index;Area under the subject operating characteristic curve;Risk ratio and relative risk ratio; | — |
Countries
China
Contacts
Public ContactZhang Lijuan
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
Outcome results
None listed